ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2023 Earnings Call Transcript

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2023 Earnings Call Transcript December 15, 2022

ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $-0.3 EPS, expectations were $-0.19.

Operator: Good morning and thank your standing by. Welcome to ImmunoPrecise Antibody’s Second Quarter Fiscal Year 2023 Earnings Conference Call. Also on the call with us today are Jennifer Bath, Chief Executive Officer; Brad McConn, Chief Financial Officer; Ilse Roodink, Chief...